Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_assertion type Assertion NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_head.
- NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_assertion description "[Although certain molecular defects are indicative of distinct cytogenetic abnormalities, others represent point mutations in critical target genes (RUNX1, N-RAS, JAK2, KIT, others) and sometimes are associated with a particular type of MDS, an overlap disease, a co-existing hematopoietic neoplasm or disease progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_provenance.
- NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_assertion evidence source_evidence_literature NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_provenance.
- NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_assertion SIO_000772 19263296 NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_provenance.
- NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_assertion wasDerivedFrom befree-20140225 NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_provenance.
- NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_assertion wasGeneratedBy ECO_0000203 NP550141.RAfXwMLaLsuUft2BKCdtJpFdbjGdJykX_VWzwJ_WekQAk130_provenance.